374Water Inc. (SCWO): Nasdaq/NYSE listing notice — 374Water appoints Stephen McKnight to board; audit committee falls below Nasdaq requirement

374Water Inc.

Director James Vanderhider resigned Feb 4, 2026 effective immediately; not due to disagreement.
Vacancy leaves audit committee with 2 members, violating Nasdaq Rule 5605(c)(2)(A); company notified Nasdaq on Feb 9 and has cure period of up to 180 days.
Stephen McKnight appointed to board Feb 9; has background in real estate and banking; will explore potential financing opportunities (expected aggregate >$120k).
Appointment made under agreement with shareholder Yaacov Nagar; Amendment No.1 provides for future board candidate replacement.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

374Water Inc. received a nasdaq noncompliance notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4)(B)).

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: audit committee
Rules: 5605(c)(2)(A), 5605(c)(4)(B)

Exact text from the filing

February 9, 2026, the Company notified Nasdaq of its non-compliance with Nasdaq Rule 5605(c)(2)(A) as a result of the Vacancy and its intent to rely on the cure period provided to the Company by Nasdaq Rule 5605(c)(4)(B). The Company intends to appoint to the Audit Committee a third director who satisfies the criteria for service on the Audit Committee by the earliest of (i) Company’s next annual meeting of stockholders and (ii) 180 days after the effectiveness of Mr. Vanderhider’s resignation. 2

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

374Water Inc. filing history →

Source: SEC EDGAR

accession 0001654954-26-001047

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.